How Centralized Fulfillment is Making Pharmacy More Efficient
Drug Topics
NOVEMBER 25, 2024
Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.
Sat.Nov 23, 2024 - Fri.Nov 29, 2024
247 
STAT+: It might be now or never for the BIOSECURE Act
STAT
NOVEMBER 27, 2024
WASHINGTON — Legislation targeting Chinese biotechnology companies caused a ruckus early this year. None of that may matter if Congress doesn’t pass it in December. The BIOSECURE Act would restrict U.S. pharmaceutical and biotechnology companies from doing business with certain Chinese companies, including WuXi AppTec and WuXi Biologics.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond
PharmaVoice
NOVEMBER 26, 2024
Stoke Therapeutics is entering phase 3 with its RNA medicine designed to treat a rare epileptic condition.
4 vitamins for post-COVID fatigue
The Checkup by Singlecare
NOVEMBER 26, 2024
When you’re sick with a viral infection, you expect to feel poorly for a few days. COVID is no exception. Whether you’re hit with respiratory, GI, or flu-like symptoms such as muscle pain, headache, and fatigue, testing positive for COVID means being down for the count for a bit before returning to your daily routine. However, what if you don’t bounce back, even after you’re technically recovered?
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Q&A: A Closer Look at the Current State of Biosimilars in the Drug Market
Drug Topics
NOVEMBER 28, 2024
Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.
STAT+: Amgen drug leads to substantial weight loss in study, but questions remain about competitiveness
STAT
NOVEMBER 26, 2024
New data from a mid-stage study of an Amgen obesity drug showed that it helped participants lose a substantial amount of weight, but questions about how competitive it could be appear to be shaping the response to the news, with the company’s share price falling on the announcement. Amgen said Tuesday that that its drug, MariTide , led to an average of roughly 20% weight loss over a year in the Phase 2 study in participants who had obesity or who were overweight without type 2 diabe
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
IVIG Demonstrates Effectiveness in Several Neuroimmune Conditions, Indicating Potential for Long COVID Treatment
Pharmacy Times
NOVEMBER 23, 2024
Intravenous immunoglobulin (IVIG) has proven efficacy in autoimmune neuropathies, with mixed but promising outcomes in severe COVID-19 cases and post-acute sequelae of SARS-CoV-2 infection trials.
Q&A: Pharmacist on Medication Developments for People Living with HIV
Drug Topics
NOVEMBER 29, 2024
Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, discussed the ongoing developments impacting patients with HIV and their prescription drugs.
Increase Pharmacy Cash Flow with These 7 Practical Steps
DiversifyRx
NOVEMBER 26, 2024
Pharmacy cash flow is still struggling even though the DIR Fee Apocalypse is over. Read on to get 7 practical tips to improve your pharmacy’s cash flow. Pharmacy cash flow is the heartbeat of your business—it keeps the lights on, the shelves stocked, and your team paid. However, in today’s pharmacy landscape, cash flow challenges are more pressing than ever.
Pharma Research Trends: Leveraging Innovation for Smarter Marketing Strategies
Pharma Marketing Network
NOVEMBER 23, 2024
Table of Contents Sr# Headings 1 Introduction 2 The Connection Between Pharma Research and Marketing 3 Precision Medicine: Targeting the Right Audience 4 AI and Big Data: Transforming Pharma Research 5 The Role of Real-World Evidence 6 Trends in Drug Development and Launch Strategies 7 Collaborations Between Pharma and Tech 8 Personalizing Marketing Through Research Insights 9 Leveraging Social Media for Research-Based Campaigns 10 The Role of Market Access Research 11 Ethical Considerations in
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Aprocitentan: A New Hope in Resistant Hypertension Management
Pharmacy Times
NOVEMBER 27, 2024
In trials, blood pressure reductions were maintained over extended periods, suggesting that the drug could offer a sustained effect.
Self-Efficacy Linked with Greater Diabetes Control in Adolescents
Drug Topics
NOVEMBER 27, 2024
A recent study found that there was a significant relationship between self-efficacy for disease control and the level of glycemic control.
Sustainable analytical approach devised for complex drug formulation
European Pharmaceutical Review
NOVEMBER 29, 2024
A novel, environmentally-friendly method has been developed for simultaneous quantification a complex anti-migraine formulation using UV spectroscopy and chemometric models. The paper highlighted that “sustainable, cost-effective, and environmentally conscious practices in pharmaceutical analysis has become a paramount imperative”. The researchers continued to explain that while a novel fixed-dose anti-migraine formulation of ergotamine (ERG), propyphenazone (PRO), caffeine (CAF), camylofin (CAM
Top Healthcare Marketing Strategies to Boost Pharmaceutical Sales
Pharma Marketing Network
NOVEMBER 24, 2024
Table of Contents Sr# Headings 1 Introduction: Why Healthcare Marketing Matters 2 Understanding the Pharma Market Landscape 3 Targeting Healthcare Professionals (HCPs) 4 The Power of Patient-Centric Marketing 5 Digital Marketing: A Game-Changer for Pharma 6 Leveraging AI in Healthcare Marketing 7 Crafting Compelling Content Strategies 8 Navigating Regulatory Compliance 9 Harnessing Data Analytics for Better Campaigns 10 Influencer Marketing in the Healthcare Space 11 Why Social Media is Vital fo
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Consequences of the Change Healthcare Cyberattack Continue
Pharmacy Times
NOVEMBER 29, 2024
Legislative efforts regarding cybersecurity are ongoing, but individuals and organizations should remain vigilant.
Intermittent Fasting, Dietary Modifications Linked to Lowered AxSpA Disease Activity | ACR Convergence
Drug Topics
NOVEMBER 27, 2024
Researchers explored the disease activity of patients with axial spondylarthritis after various modifications to their diets.
STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger
STAT
NOVEMBER 26, 2024
Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug development , laid off employees after closing a merger last week.
Mount Sinai opens doors to new $100M research site for AI development
Fierce Healthcare
NOVEMBER 26, 2024
Mount Sinai Health System has opened the doors of its new AI research center in Manhattan, the Hamilton and Amabel James Center for AI and Human Health. | Mount Sinai Health System announced on Tuesday that it opened its Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which will be a research site for AI development.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA Approves Methylene Blue Injection for Acquired Methemoglobinemia
Pharmacy Times
NOVEMBER 27, 2024
Methemoglobinemia is a blood disorder that affects proper release of oxygen around the body.
How Pharmacists Can Stay Updated on Advancements in Diabetes Care
Drug Topics
NOVEMBER 26, 2024
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, talks about the best ways pharmacists can stay updated on advancements in diabetes medications and treatments.
Specialized CROs aim to boost participation among women and other underrepresented groups
PharmaVoice
NOVEMBER 27, 2024
Lindus Health’s women-focused CRO is the latest in a handful of research efforts to target specialized — and underrepresented — populations.
CMS finalizes 6-year kidney transplant model with concessions to hospital lobby after critiques
Fierce Healthcare
NOVEMBER 26, 2024
The Centers for Medicare & Medicaid Services (CMS) finalized a six-year mandatory model to increase access to kidney transplants, the agency announced Nov. 26. | CMS made some concessions to hospitals who strongly criticized the kidney transplant model proposed rule in May.
Empowering Diabetes Care: The Evolving Role of Pharmacists
Pharmacy Times
NOVEMBER 27, 2024
Pharmacists are well-positioned to address diabetes from a multifaceted approach.
Patients with Gout More Likely to Experience Ischemic Colitis | ACR Convergence
Drug Topics
NOVEMBER 26, 2024
Researchers aimed to address the associations between gout and ischemic events, specifically ischemic colitis.
AI and automation to drive “substantial progress” in pharmaceutical analytical testing
European Pharmaceutical Review
NOVEMBER 25, 2024
The pharmaceutical analytical testing market is seeing significant growth following a greater incidence in the complexity of medicine development and higher demand for biologics and biosimilars, according to a report by Straits Research Pvt. Ltd. Their analysis projected that the market will exceed a value of $15.46 billion by 2032. The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 percent between 2024 and 2032.
Biden proposes Medicare, Medicaid cover anti-obesity drugs
Fierce Healthcare
NOVEMBER 26, 2024
The Centers for Medicare & Medicaid Services (CMS) is attempting to cover anti-obesity medications under Medicare Part D and Medicaid, the agency announced Nov. 26. | With time running out before leaving office, the Biden administration is proposing a rule to have Medicare and Medicaid cover anti-obesity medications and bolster guardrails for AI, among the changes.
PBM Price Negotiations Have Unintended Consequences for Independent Pharmacies
Pharmacy Times
NOVEMBER 27, 2024
However, pharmacists can help mitigate these effects.
Independent Pharmacist on Navigating the Dynamic Pharmacy Profession
Drug Topics
NOVEMBER 26, 2024
Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.
Digital transformation expected to shorten drug development timelines
Pharmaceutical Technology
NOVEMBER 27, 2024
Pharmaceutical professionals expect digital solutions to solve drug development headaches, with AI already proving disruptive.
Cambridge Health Alliance taps Abridge's AI medical scribe to support multilingual patients
Fierce Healthcare
NOVEMBER 26, 2024
Providers are rapidly adopting generative AI-based clinical documentation tools to aid clinicians and make digital paperwork more efficient. | Cambridge Health Alliance, the only public academic health system in Massachusetts, is deploying Abridge's AI-based medical note-taking tool across its 600 clinicians after a successful pilot.
FDA Approves Oral Liquid Solution of Imatinib for Certain Forms of Leukemia and Other Cancers
Pharmacy Times
NOVEMBER 25, 2024
This is the first oral liquid form of imatinib (Imkeldi; Shorla Oncology) to be approved to treat cancers.
Q&A: How a Community Pharmacist is Helping Other Pharmacies Through Consulting
Drug Topics
NOVEMBER 25, 2024
Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, joined Drug Topics to discuss his career journey.
Transforming pharmacovigilance: The revolutionary impact of generative AI on drug safety
pharmaphorum
NOVEMBER 26, 2024
Discover the revolutionary impact of generative artificial intelligence (GenAI) on drug safety in pharmacovigilance. Learn how this cutting-edge technology is transforming the industry.
Let's personalize your content